Kazatomprom Reports 17 Production Surge in Q3 Signaling Potential Supply Growth Soleno Therapeutics Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline ImmunityBio Gains Momentum as FDA Accepts ANKTIVA sBLA for Bladder Cancer Expansion